SeaStar Medical Holding Corp
Research SeaStar Medical Holding Corp (ICU) on Bullrun: market cap USD 13.55M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerICU
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 13.55M
- Financial periodQ1 2026
- RevenueUSD 1.44M
- Net income-USD 3.52M
- Free cash flow-USD 2.76M
- Gross margin31.3%
Valuation Snapshot
latest market cap is USD 13.55M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.23M | -USD 12.15M | -USD 13.60M | 95.7% | -8.3 | USD 11.98M | USD 525.00K | USD 10.42M |
| FY2024 | USD 135.00K | -USD 24.83M | -USD 16.01M | 100.0% | -6.63 | USD 1.82M | USD 574.00K | -USD 2.18M |
| FY2023 | USD 0 | -USD 26.23M | n/a | n/a | -30.26 | USD 176.00K | USD 4.71M | -USD 13.87M |
| FY2022 | n/a | -USD 12.19M | n/a | n/a | -1.48 | USD 47.00K | USD 8.83M | -USD 20.76M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 13.55M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 9.23M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 11.60M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 19.71M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 52.07M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | n/a | 1172.9 | n/a | n/a |
About SeaStar Medical Holding Corp
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SeaStar Medical Holding Corp's market cap?
SeaStar Medical Holding Corp's market capitalization is USD 13.55M.
What does SeaStar Medical Holding Corp do?
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis.